Skip to content

Trimport

by Gerard Medical Enterprises, Inc. 2 variants

510(k) K945250

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

7 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK945250 Date7 Mar 1995ClearedStatusActive

Recalls

7 recalls · FDA

  • 7 recalls, same reason

    • Terminated Z-1882-2010 FDA Unclassified (pre-2012) initiated 13 May 2010
    • Terminated Z-1886-2010 FDA Unclassified (pre-2012) initiated 13 May 2010
    • Terminated Z-1885-2010 FDA Unclassified (pre-2012) initiated 13 May 2010
    • Terminated Z-1887-2010 FDA Unclassified (pre-2012) initiated 13 May 2010
    • Terminated Z-1881-2010 FDA Unclassified (pre-2012) initiated 13 May 2010
    • Terminated Z-1883-2010 FDA Unclassified (pre-2012) initiated 13 May 2010
    • Terminated Z-1884-2010 FDA Unclassified (pre-2012) initiated 13 May 2010

    FDA testing determined that non-coring needles included in the Vaxcel Port and Vaxcel Port with PASV Valve may result in coring and resulting septum damage which could lead to patient injury.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LJT
Device Class
Class II
Regulation
21 CFR Part 880.5965
Advisory Committee
General Hospital
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The TrimPort Implantable Access System is a subcutaneous, implanted port and catheter device designed for intravascular access. It facilitates repeated vascular access for parenteral administration of fluids and blood withdrawal, serving as a long-term solution for patients requiring frequent intravenous therapies or sampling.

This device is supplied sterile and intended for single-use implantation. It is classified under product code LJT and falls under FDA 510(k) clearance (K945250) as substantially equivalent to the predicate device. The system is intended for use in general hospital settings and adheres to regulatory requirements outlined under 880.5965. No MRI safety information or reusable specifications are indicated in the data.

Other devices from Gerard Medical Enterprises, Inc.

See all devices from Gerard Medical Enterprises, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the TrimPort Implantable Access System used for?

    The TrimPort Implantable Access System is designed for repeated intravascular access, enabling the parenteral administration of fluids and blood withdrawal. It serves as a long-term solution for patients requiring frequent intravenous therapies or blood sampling, providing reliable and convenient access without repeated needle insertions.

  • Is the TrimPort supplied sterile and intended for single-use?

    Yes, the TrimPort is supplied sterile and is intended for single-use implantation. This ensures patient safety by minimizing the risk of infection and contamination associated with reusable devices.

  • What type of medical facility is the TrimPort intended for?

    The TrimPort is classified under product code LJT and is intended for use in general hospital settings. Its design and regulatory compliance align with standards for devices used in clinical environments requiring sterile, long-term vascular access.

  • Does the TrimPort have any MRI safety information?

    The provided data does not include any specific MRI safety information for the TrimPort Implantable Access System. Patients or clinicians should consult the manufacturer’s instructions or additional documentation for MRI-related precautions before use.

  • What regulatory pathway does the TrimPort follow?

    The TrimPort Implantable Access System follows the FDA 510(k) clearance pathway, specifically classified as substantially equivalent to a predicate device under the FDA’s regulations. It holds clearance number K945250 and adheres to regulatory requirements outlined under 880.5965.